Nuwellis announces strong Q4 console sales and strategic Rendiatech acquisition
Nuwellis (NASDAQ:NUWE), a commercial-stage medical device company focused on transforming the care of patients with fluid overload, reported fourth-quarter 2025 revenue of $2.4 million on Tuesday.











